Metastatic pancreatic cancer: Another option.
dc.contributor.author | Shrikhande, Shailesh V | |
dc.contributor.author | Gupta, Sudeep | |
dc.contributor.author | Ostwal, Vikas | |
dc.date.accessioned | 2012-06-27T10:32:30Z | |
dc.date.available | 2012-06-27T10:32:30Z | |
dc.date.issued | 2011-11 | |
dc.identifier.citation | Shrikhande Shailesh V, Gupta Sudeep, Ostwal Vikas. Metastatic pancreatic cancer: Another option. National Medical Journal of India. 2011 Nov-Dec; 24(6): 356-357. | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/139243 | |
dc.language.iso | en | en_US |
dc.source.uri | https://www.nmji.in/archives/Volume-24/Issue-6/Selected-Summaries-I.pdf | en_US |
dc.subject.mesh | Antimetabolites, Antineoplastic --adverse effects | |
dc.subject.mesh | Antimetabolites, Antineoplastic --therapeutic use | |
dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols --adverse effects | |
dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols --therapeutic use | |
dc.subject.mesh | Camptothecin --administration & dosage | |
dc.subject.mesh | Camptothecin --analogs & derivatives | |
dc.subject.mesh | Deoxycytidine --analogs & derivatives | |
dc.subject.mesh | Deoxycytidine --therapeutic use | |
dc.subject.mesh | Female | |
dc.subject.mesh | Fluorouracil --administration & dosage | |
dc.subject.mesh | Follow-Up Studies | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Leucovorin --administration & dosage | |
dc.subject.mesh | Male | |
dc.subject.mesh | Neoplasm Metastasis --drug therapy | |
dc.subject.mesh | Pancreatic Neoplasms --drug therapy | |
dc.subject.mesh | Pancreatic Neoplasms --mortality | |
dc.subject.mesh | Pancreatic Neoplasms --pathology | |
dc.subject.mesh | Proportional Hazards Models | |
dc.subject.mesh | Quality of Life | |
dc.subject.mesh | Severity of Illness Index | |
dc.subject.mesh | Survival Analysis | |
dc.title | Metastatic pancreatic cancer: Another option. | en_US |
dc.type | Article | en_US |